Skip to content

Clinical trials

Terminated Thrombocytopenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Status: Terminated Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20051
20061
20072
20083
20092
20103
20112
20122
20133
20143
20151
20173
20183
20192
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CTI BioPharma2
M.D. Anderson Cancer Center2
Shionogi2
Sobi, Inc.2
Archemix Corp.1
Carelon Research1
Cellphire Therapeutics, Inc.1
Dana-Farber Cancer Institute1
Emory University1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia38
Hematologic Diseases6
Primary Myelofibrosis5
Hepatitis C4
Myelodysplastic Syndromes4
Purpura, Thrombocytopenic, Idiopathic4
Anemia3
Hematologic Neoplasms3
Multiple Myeloma3
Myeloproliferative Disorders3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.